CCP allows Citi Pharma to acquire Pakheim
KARACHI: The Competition Commission of Pakistan (CCP) has authorised Citi Pharma Limited’s proposed acquisition of 100 percent shareholding in Pakheim International Pharma (Private) Limited, determining that the transaction does not raise competition concerns...
KARACHI: The Competition Commission of Pakistan (CCP) has authorised Citi Pharma Limited’s proposed acquisition of 100 percent shareholding in Pakheim International Pharma (Private) Limited, determining that the transaction does not raise competition concerns. In a material information notice submitted to the Pakistan Stock Exchange (PSX) on October 16, Citi Pharma said it had received the CCP’s order dated October...